Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Kane Biotech Inc. (V:KNE)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for KNE within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 28, 2020 10:02 ET
IIROC Trading Resumption - KNE
VANCOUVER, BC, Sept. 28, 2020 /CNW/ - Trading resumes in:
Read full article
Sep 28, 2020 09:45 ET
Kane Biotech and Animalcare to Form Animal Health Company to Target Biofilm-Related Ailments
Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”) today announced that it has entered into an agreement with UK-based veterinary products company, Animalcare Group PLC (AIM:ANCR,”Animalcare”), under which the parties will form STEM...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.18
--
--
Price to Sales - TTM
9.67
15.57
9.84
Price to Book - most recent quarter
107.98
3.63
2.88
Price to Cash Flow per share - TTM
--
12.67
10.78
Price to Free Cash Flow per share - TTM
--
41.11
16.48
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 202046,054-107,297
Aug 31, 2020153,351124,351
Aug 15, 202029,00010,485
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company's technologies include DispersinB, AloSera, Aledex, Strix NB, bluestem and KBI Disinfectant. It is focused on the companion animal market with Strix NB brand for the veterinary segment and bluestem brand for the pet over the counter (OTC) retail market. The Company markets its oral care technology into the Canadian pet specialty market under the bluestem brand. It has over 100 pet specialty stores in Canada, which are engaged in selling the bluestem oral health products. It has various formulations in development, including formulations with antibiotics and the antibiofilm enzyme beta-N-Acetylglucosaminidase and antibiofilm-antimicrobial formulations for both the veterinary and human markets. It is focused on the development of oral care spray formulation and a water additive powder formulation.

See business summary

 

Twitter

Search (past week) for $KNE.CA KNE.V

  • No tweets found